Lars Soendergaard MD, MSc

Lars Soendergaard Graduated in 1988 from the University of Copenhagen. Trained in Cardiology at Rigshospitalet in Copenhagen, as well as Great Ormond Street Hospital for Sick Children and The Heart Hospital in London. Special interest in congenital and structural heart diseases, particular interventional procedures, and Head of these programs at Rigshospitalet in Copenhagen. Led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012. Professor of Cardiology at the University of Copenhagen. Published 338 peer-reviewed articles, and 16 textbook chapters.

Soendergaard research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions. Lead principal investigator for several trials including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomized trial (PFO vs anti-platelet therapy after cryptogenic stroke).